Phastar - recognizing the power of data in improving staff well-being
In today's fast-paced and demanding work environment, the importance of prioritizing employee mental health cannot be overstated.
Archives for May 9, 2024
Significant strides made in Nxera Pharma's oral compound for neurological conditions
Neurocrine Biosciences Inc. has initiated its phase 1 clinical study, marking a significant stride in the evaluation of NBI-1117567, an investigational small molecule, oral compound developed by Nxera Pharma.
Report highlights challenges facing life sciences sector amid economic turbulence
A collaborative report released today (May 9) by Medicines Discovery Catapult (MDC), sheds light on the challenges facing the life sciences sector amidst recent economic turbulence.